FIELD: medicine.
SUBSTANCE: method involves introducing therapeutic doses of lentiviral vector containing angiogenesis-regulating gene.
EFFECT: enhanced effectiveness in controlling intraocular cell proliferation and neovascularization.
8 cl, 34 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDES OF DIRECTED ACTION OF VEGFR-1/NRP-1 | 2008 |
|
RU2488592C2 |
| RECOMBINANT HYBRID POLYPEPTIDE, CAPABLE OF INHIBITING HUMAN ENDOTHELIAL CELL PROLIFERATION IN VITRO, AND METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2465283C1 |
| PEPTIDES FOR INHIBITING ANGIOGENESIS | 2016 |
|
RU2708375C2 |
| COMPOSITIONS AND METHODS FOR INSERTION OF TUBULIN-BINDING AGENTS FOR EYE DISEASE THERAPY | 2002 |
|
RU2354398C2 |
| MULTIPURPOSE AND POLYVALENT INHIBITORS OF ANGIOGENESIS | 2005 |
|
RU2398878C2 |
| INHIBITORS OF HISTONDEACETYLASE FOR TREATMENT OF OPHTHALMOLOGIC NEOVASCULAR DISTURBANCES AND DISEASES | 2003 |
|
RU2352337C2 |
| FUSED PROTEIN WITH EFFECT OF ANGIOGENESIS INHIBITOR | 2008 |
|
RU2372354C1 |
| COMPOSITIONS AND WAYS OF INJECTIONS OF AGENTS BINDING TUBULIN, FOR TREATMENT OF EYE DISEASES | 2004 |
|
RU2359693C2 |
| METHODS OF INHIBITING OCULAR ANGIOGENESIS | 2009 |
|
RU2530583C2 |
| TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS | 2018 |
|
RU2815482C2 |
